Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
06/2000
06/13/2000US6075008 Method for promoting cell proliferation and growth
06/13/2000US6075007 Modified noggin polypeptide and compositions
06/13/2000US6075004 Peptide compositions which induce immune tolerance and methods of use
06/13/2000US6074875 Materials and methods relating to the regulation of polypeptide production in cells
06/13/2000US6074873 Nucleic acids encoding NL-3
06/13/2000US6074872 Nucleic acid sequence coding a nervous system polypeptide; for inducing sleep in mammals and the treatment of sleep defects; for screening potential modulators of sleep
06/13/2000US6074865 Recombinant viral nucleotide sequences which code envelope protein; for the development of a vaccine for treatment and prevention of viral infection
06/13/2000US6074852 Producing mannose-terminated protein by culturing host cell transformed with gene from e1 or e2 region, causing expression but inhibiting sialylation, isolating glycoprotein using mannose-binding protein
06/13/2000US6074850 Includes a dna binding domain of an e2f transcription factor and a functional growth suppression domain of retinoblastoma; lacks functional cyclin a-kinase binding domain of factor; antiproliferative agents especially against restenosis
06/13/2000US6074849 Polynucleotides encoding human CTLA-8 related proteins
06/13/2000US6074848 Amino acid sequence; for antiproliferative and wound healing agents
06/13/2000US6074847 Nucleotide and amino acid sequence for essential integral membrane protein with adenosine triphosphatase domain at its c-terminus; involved in degradation of a heat shock transcription factor; for screening bactericides
06/13/2000US6074846 Hepatitis C virus asialoglycoproteins
06/13/2000US6074845 Nucleic acid encoding a bovine calcitonin receptor-like receptor (BECRLR)
06/13/2000US6074844 Polynucleotides encoding human membrane fusion proteins
06/13/2000US6074843 Amino acid and nucleotide sequences of gene involved in controlling transcription; for diagnosis, prevention, and treatment of respiratory, developmental, and nervous system disorders; for antisense agents
06/13/2000US6074842 Amino acid and nucleotide sequences of human protein useful as markers to distinguish adipocytes from non-adipocyte, pathophysiologically lipid-laden cells; for probes and antibodies
06/13/2000US6074841 Don-1 gene and polypeptides and uses therefor
06/13/2000US6074840 Recombinant production of latent TGF-beta binding protein-3 (LTBP-3)
06/13/2000US6074839 Transforming growth factor αHI
06/13/2000US6074836 Method of marking eukaryotic cells
06/13/2000US6074832 DNA encoding canine von Willebrand factor and methods of use
06/13/2000US6074828 Screening compounds by transforming cell with recombinant expression contruct which expresses excitatory amino acid transporter and analyzing cell to determine if compound binds to transporter
06/13/2000US6074819 DNA replication-regulating genes
06/13/2000US6074817 Recombinant mono and poly antigens to detect cytomegalovirus-specific IgM in human sera by enzyme immunoassay
06/13/2000US6074816 Oligonucleotides which hybridize to genome of non a and non b hepatitis virus; for probes and primers
06/13/2000US6074650 Membrane anchor/active compound conjugate, its preparation and its uses
06/13/2000US6074649 Recombinant composition containing feline herpes virus type 1, particularly for treating feline infectious peritonitis
06/13/2000US6074646 Nondenatured HIV envelope antigens for detecting early HIV-specific antibodies
06/13/2000US6074645 Immuno-reactive peptide CTL epitopes of human cytomegalovirus
06/13/2000US6074643 Site-directed chemotherapy of metastases
06/13/2000US6074642 Reduce cell lysing ability of biological complement present in blood
06/13/2000US6074639 Ex vivo expansion of hematopoietic cells using interleukin-3 (IL-3) variant fusion proteins
06/13/2000US6074636 Method of using cell surface receptor targeted molecules for the treatment of viral diseases
06/13/2000US6074635 T cell activation
06/13/2000US6074627 Stable complex
06/13/2000CA2159079C Methods and dna expression systems for over-expression of proteins in host cells
06/13/2000CA2157196C Inhibitors of herpes viral ribonucleotide reductase
06/13/2000CA2137072C Conformationally restrained peptide analogs as antiplatelet agents
06/13/2000CA2118309C Lymphocyte activation antigen hb15, a member of the immunoglobulin superfamily
06/13/2000CA2079105C Hepatitis c virus protease
06/13/2000CA2077537C Therapeutically useful peptides and peptide fragments
06/13/2000CA2048450C Antisense oligonucleotide antibiotics complementary to the macromolecular synthesis operon, methods of treating bacterial infections and methods for identification of bacteria
06/13/2000CA2036398C Hiv protease inhibiting agents
06/13/2000CA1341026C Il-1 inhibitors process for producing il-1 inhibitors and for using such inhibitors in therapy
06/13/2000CA1341023C Peptide derivatives
06/13/2000CA1341022C Prepro-lhrh c-terminal peptide
06/13/2000CA1341021C Hepatitis surface antigen particle vaccine
06/11/2000CA2255477A1 Human vitreous and pharmaceutical compositions
06/09/2000CA2290711A1 Methods for diagnosing a form of ataxia and compounds for use in the method
06/09/2000CA2289951A1 Processes for preparation of marek's disease virus using continuous avian cell lines
06/09/2000CA2286312A1 Peptide fragments derived from cwpm23, a protein involved in freezing resistance of winter wheat
06/08/2000WO2000033084A2 Arrays of organic compounds attached to surfaces
06/08/2000WO2000033077A1 Cell matrix plaques of initial bone formation
06/08/2000WO2000033068A1 Therapeutic and diagnostic tools for impaired glucose tolerance conditions
06/08/2000WO2000032825A2 Development of anti-microbial agents based on bacteriophage genomics
06/08/2000WO2000032823A1 Dna-protein fusions and uses thereof
06/08/2000WO2000032802A1 Hiv vaccine
06/08/2000WO2000032797A1 Transformed thermomyces lanuginosus
06/08/2000WO2000032796A2 Kinetoplastid protein expression system
06/08/2000WO2000032794A2 Chlamydia antigens and corresponding dna fragments and uses thereof
06/08/2000WO2000032786A1 gp120 MUTANTS AND BIOLOGICAL APPLICATIONS
06/08/2000WO2000032785A1 Isolation and characterization of a n. crassa silencing gene and uses thereof
06/08/2000WO2000032784A1 Chlamydia antigens and corresponding dna fragments and uses thereof
06/08/2000WO2000032783A1 Plant transcription factors
06/08/2000WO2000032782A2 Plant transcription factors
06/08/2000WO2000032780A1 Control of flowering
06/08/2000WO2000032779A1 Nucleic acids and polypeptides of d. melanogaster insulin-like genes and uses thereof
06/08/2000WO2000032778A2 Methods and compositions for inhibiting neoplastic cell growth
06/08/2000WO2000032777A2 Scorpion toxins
06/08/2000WO2000032776A2 Secreted amd transmembrane polypeptides and nucleic acids encoding the same
06/08/2000WO2000032775A1 Pth1r and pth3r receptors
06/08/2000WO2000032774A1 12216 receptor, a g-protein coupled receptor
06/08/2000WO2000032773A1 Compositions and methods for increasing bone mineralization
06/08/2000WO2000032772A2 Erythropoietic compounds
06/08/2000WO2000032771A1 Pth1r and pth3r receptors, methods and uses thereof
06/08/2000WO2000032770A1 Novel tumor antigen protein art-1 and tumor antigen peptide thereof
06/08/2000WO2000032769A2 Mage-10 or mage-8 derived hla-a2.1-binding oligopeptides
06/08/2000WO2000032768A1 Polypeptides capable of interacting with the human topoisomerase iii alpha
06/08/2000WO2000032767A1 RECOMBINANT SOLUBLE Fc RECEPTORS
06/08/2000WO2000032766A1 Human vanilloid receptors and their uses
06/08/2000WO2000032764A1 New oligomeric conjugates liable to transfer biological molecules into cells
06/08/2000WO2000032761A1 Ethylene-response-factor1 (erf1) in plants
06/08/2000WO2000032760A1 Method of increasing growth and yield in plants
06/08/2000WO2000032755A1 Stable, attenuated rabies virus mutants and live vaccines thereof
06/08/2000WO2000032754A1 An improved method for the production and purification of adenoviral vectors
06/08/2000WO2000032752A1 Psca: prostate stem cell antigen and uses thereof
06/08/2000WO2000032751A2 Mammalian non-neuronal cells that are modified to store and release a neurotransmitter
06/08/2000WO2000032746A2 Netrin-like and ependymin-like nucleic acids and polypeptides and uses thereof
06/08/2000WO2000032745A2 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof
06/08/2000WO2000032633A1 Novel adhesion molecule and methods of use
06/08/2000WO2000032632A2 Allo- and auto-reactive t-cell epitopes from rhesus protein and their use
06/08/2000WO2000032631A2 Proteins that bind angiogenesis-inhibiting proteins, compositions and methods of use thereof
06/08/2000WO2000032630A2 Nucleic acids and polypeptides derived from activated eosinophil cells and use thereof
06/08/2000WO2000032629A2 Antiviral peptides
06/08/2000WO2000032628A1 ReL1A BINDING INHIBITOR, PROCESS FOR PRODUCING THE SAME AND UTILIZATION THEREOF
06/08/2000WO2000032627A1 Novel physiologically active substance, process for producing the same and utilization thereof
06/08/2000WO2000032626A1 Methods of using epitope peptides of human pathogens
06/08/2000WO2000032625A1 Hbv core antigen particles with multiple immunogenic components attached via peptide ligands
06/08/2000WO2000032624A2 Uncoupling protein 5 - ucp5
1 ... 2151 2152 2153 2154 2155 2156 2157 2158 2159 2160 2161 2162 2163 2164 2165 2166 2167 2168 2169 2170 2171 ... 2916